Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease
Open Access
- 21 August 2014
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 13 (1) , 1-9
Abstract
Although no receptor has yet been identified, changes in circulating levels of the adipokine designated as Omentin have been demonstrated in obesity and related comorbidities such as cardiovascular disease, insulin resistance, metabolic syndrome and chronic inflammation. Changes in Omentin levels at 1 and 5 days and 6 and 12 months in response to biliopancreatic diversion with duodenal switch bariatric surgery were evaluated, specifically to investigate if changes preceded gain of insulin sensitivity. Pre-operative plasma Omentin was not different between men (n = 18) vs women (n = 48), or diabetic status but correlated with body mass index (BMI). Altogether, Omentin increased as early as 24-h post-surgery, with changes maintained up to 1-year. Fifty-nine percent of subjects increased Omentin >10% by 24-H following surgery (OmentinINC p < 0.0001), while 18% of subjects decreased (OmentinDEC p < 0.0001), with changes maintained throughout one-year. These two groups had comparable age, sex distribution, diabetes, BMI, waist circumference and fat mass, however OmentinDEC had elevated levels of cardiovascular risk markers; homocysteine (p = 0.019), NT-proBNP (p = 0.006) and total bilirubin (p = 0.0001) while red blood cell (RBC) count was lower (p = 0.0005) over the one-year period. Omentin levels at 1-DAY also correlated with immune parameters (white blood cell count, % neutrophil, % monocytes, % lymphocytes). OmentinDEC at 1 day following surgery may be a marker of cardiovascular “at-risk” group before weight loss or insulin sensitivity restoration.Keywords
This publication has 38 references indexed in Scilit:
- Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese womenNutrition & Diabetes, 2012
- Omentin as a novel biomarker of metabolic risk factorsDiabetology & Metabolic Syndrome, 2012
- Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetesCardiovascular Diabetology, 2011
- Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart diseaseDiabetic Medicine, 2011
- Obesity, weight loss and conditional cardiovascular risk factorsObesity Reviews, 2011
- The Relationship among Homocysteine, Bilirubin, and Diabetic RetinopathyDiabetes & Metabolism Journal, 2011
- Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese menJournal of Sports Sciences, 2010
- Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: Relevance to oxidative stressAtherosclerosis, 2010
- Circulating omentin concentration increases after weight lossNutrition & Metabolism, 2010
- Effects of Bariatric Surgery on Inflammatory, Functional and Structural Markers of Coronary AtherosclerosisThe American Journal of Cardiology, 2009